BCCIP and lung adenocarcinoma: Overexpression of BCCIP is associated with shorter survival time of patients with lung adenocarcinoma, and in vitro experiments showed that interference of BCCIP inhibits the proliferation of lung adenocarcinoma and blocks in G1/S phase.